|
|
|
|
Cilostazol Improves Platelet Reactivity, Not Clinical Outcomes in DES Patients
ATLANTA, GATriple antiplatelet therapy with cilostazol added to clopidogrel and aspirin lowers platelet reactivity compared with standard dual therapy in patients receiving drug-eluting stents (DES), but these results do not translate to fewer ischemic events,...
|
|
|
Hybrid revascularization procedure is safe and feasible for left main coronary artery stenosis
The left main coronary artery provides most of the blood to the heart, and current guidelines call for patients with blockages in this artery to undergo bypass surgery.Hybrid revascularization is a combination of coronary artery bypass surgery and...
|
|
|
New cerebral protection device prevents stroke during treatment to clear blocked carotid arteries
Cerebral protection device used in combination with minimally invasive FDA-approved carotid stents in high-surgical-risk patients advances stroke care, shows excellent safety, effectiveness outcomes An important interventional radiology advancement-the use of a...
|
|
|
Sleep Interventions Improve Quality of Life in Older Patients With Alzheimer's Disease, Dementia: Presented at
-- Interventions to improve the sleep cycles of patients with Alzheimer's disease (AD) and dementia have beneficial effects on the distress experienced by all patients and improved sleep cycles in some patients, according to a study reported here at the 25th...
|
|
|
ACC: Aspirin as Effective as Dual Antiplatelet Therapy for Stents
MONDAY, March 15 (HealthDay News) -- In patients who have received drug-eluting stents, dual antiplatelet therapy longer than 12 months is no more effective than aspirin monotherapy in decreasing the rate of heart attack or death from cardiovascular causes,...
|
|
|
SIR: Cerebral protection device 98% effective in high-risk CAD cases
Use of the Mo.Ma proximal cerebral protection device (Invatec) used with FDA-approved carotid stents in high-risk patients are 98 percent effective and proved to decrease risk of stroke, according to results of the ARMOUR trial presented by Barry T. Katzen...
|
|
|
Hybrid revascularization effective for left main coronary blockages
The left main coronary artery provides most of the blood to the heart, and current guidelines call for patients with blockages in this artery to undergo bypass surgery.Hybrid revascularization is a combination of coronary artery bypass surgery and...
|
|
|
Device advances interventional radiology treatment to clear blocked carotid arteries, prevent stroke
Cerebral protection device used in combination with minimally invasive FDA-approved carotid stents in high-surgical-risk patients advances stroke care, shows excellent safety, effectiveness outcomes TAMPA, Fla.(March 15, 2010)An important interventional...
|
|
|
CILON-T: Triple antiplatelet therapy associated with improved platelet reactivity
ATLANTA Patients implanted with stents may have improved platelet activity when assigned to a triple antiplatelet therapy regimen compared with a dual-antiplatelet therapy regimen, study results indicated.Researchers for the 22 factorial CILON-T study...
|
|
|
Neurological disorders in a rural Western Australian population
Background: There is limited information on the causes of neurological disorders in an Australian rural setting.Methods: This study reports on a prospective cohort of 160 patients (95 women and 65 men) with a mean age of 55.1 years (standard deviation 19.78...
|
|
|
A Model of Indispensability of a Large Glial Layer in Cerebrovascular Circulation
_ A Model of Indispensability of a Large Glial Layer in Cerebrovascular Circulation.
|
|
|
Aton Pharma Launches Authorized Generic Version of Glaucoma Eye Drop Timoptic-XE Gel Forming Solution
Aton Pharma, Inc., a diversified specialty pharmaceutical company, today announced that it has launched an authorized generic version of its Timoptic-XE (timolol maleate ophthalmic gel forming solution).Timoptic-XE is a non-selective beta-adrenergic receptor...
|
|
|
RF ablation reduces pain in bone cancer patients
ADHD AIDS Asthma Community Acquired MRSA Cardiovascular Diseases Cerebrovascular Diseases COPD Depression Diabetes Endocrine Diseases Geriatrics GI Disorders H1N1 Resources Headache High Cholesterol HPV Hypertension Insomnia Infection Managing Asthma...
|
|
|
Aton Pharma Launches Authorized Generic Version of Glaucoma Eye Drop Timoptic-XE Gel Forming Solution
Aton Pharma, Inc., a diversified specialty pharmaceutical company, today announced that it has launched an authorized generic version of its Timoptic-XE (timolol maleate ophthalmic gel forming solution).Timoptic-XE is a non-selective beta-adrenergic receptor...
|
|
|
A Long-Term Study of Changes in the Volume of Brain Ventricles and White Matter Lesions After Successful Liver Transplantation
Background.A prolonged survival in liver transplant recipients due to a better management exposes them to multiple factors that can impair neurologic function in the long term. Methods. Twenty-two patients were studied by brain magnetic resonance and...
|
|
|
China Nuokang Bio-Pharmaceutical Inc. to Report Fourth Quarter and Full Year 2009 Financial Results
(GLOBE NEWSWIRE) -- China Nuokang Bio-Pharmaceutical Inc.(Nasdaq:NKBP - News) ('Nuokang' or the 'Company'), a leading China-based biopharmaceutical company focused on the research, development, manufacture, marketing and sales of hematological and...
|
|
|
These 3 dermatologic disorders often have similar characteristics. Can you tell which is which?
ADHD AIDS Asthma Community Acquired MRSA Cardiovascular Diseases Cerebrovascular Diseases COPD Depression Diabetes Endocrine Diseases Geriatrics GI Disorders H1N1 Resources Headache High Cholesterol HPV Hypertension Insomnia Infection Managing Asthma...
|
|
|
Aton Pharma Launches Authorized Generic Version of Glaucoma Eye Drop Timoptic-XE(R) Gel Forming Solution
Aton Pharma, Inc., a diversified specialty pharmaceutical company, today announced that it has launched an authorized generic version of its Timoptic-XE (timolol maleate ophthalmic gel forming solution).Timoptic-XE is a non-selective beta-adrenergic receptor...
|
|
|
Aton Pharma Launches Authorized Generic Version of Glaucoma Eye Drop Timoptic-XE(R) Gel Forming Solution
Aton Pharma, Inc., a diversified specialty pharmaceutical company, today announced that it has launched an authorized generic version of its Timoptic-XE (timolol maleate ophthalmic gel forming solution).Timoptic-XE is a non-selective beta-adrenergic receptor...
|
|
|
Aton Pharma Launches Authorized Generic Version of Glaucoma Eye Drop Timoptic-XE(R) Gel Forming Solution
Aton Pharma, Inc., a diversified specialty pharmaceutical company, today announced that it has launched an authorized generic version of its Timoptic-XE (timolol maleate ophthalmic gel forming solution).Timoptic-XE is a non-selective beta-adrenergic receptor...
|
|
|
Drugmakers Nix Long-Term Study On ADHD Meds
A confidential report issued last fall by Novartis on behalf of several drugmakers that sell ADHD meds concludes it isnt feasible to conduct an observational, comparative long-term study to validate a signal of adverse psychiatric or cognitive outcomes from the...
|
|
|
Aton Pharma Launches Authorized Generic Version of Glaucoma Eye Drop Timoptic-XE(R) Gel Forming Solution
Aton Pharma, Inc., a diversified specialty pharmaceutical company, today announced that it has launched an authorized generic version of its Timoptic-XE (timolol maleate ophthalmic gel forming solution).Timoptic-XE is a non-selective beta-adrenergic receptor...
|
|
|
Aton Pharma Launches Authorized Generic Version of Glaucoma Eye Drop Timoptic-XE(R) Gel Forming Solution
Aton Pharma, Inc., a diversified specialty pharmaceutical company, today announced that it has launched an authorized generic version of its Timoptic-XE (timolol maleate ophthalmic gel forming solution).Timoptic-XE is a non-selective beta-adrenergic receptor...
|
|
|
Aton Pharma Launches Authorized Generic Version of Glaucoma Eye Drop Timoptic-XE(R) Gel Forming Solution
Aton Pharma, Inc., a diversified specialty pharmaceutical company, today announced that it has launched an authorized generic version of its Timoptic-XE (timolol maleate ophthalmic gel forming solution).Timoptic-XE is a non-selective beta-adrenergic receptor...
|
|
|
Aton Pharma Launches Authorized Generic Version of Glaucoma Eye Drop Timoptic-XE(R) Gel Forming Solution
LAWRENCEVILLE, N.J.'Authorized generics are a very effective sales strategy for Aton Pharma's product portfolio,' stated Michael G. Wells Aton's U.S. Timoptic product line includes Timoptic (timolol maleate) Ophthalmic Solution, Timoptic (timolol maleate...
|
